These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
378 related articles for article (PubMed ID: 1920939)
1. [Clinical study of concerning factors of decreased bone mineral content in hemodialysis patients]. Kohara N Nihon Jinzo Gakkai Shi; 1991 Jun; 33(6):587-96. PubMed ID: 1920939 [TBL] [Abstract][Full Text] [Related]
2. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis. Brandi L Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159 [TBL] [Abstract][Full Text] [Related]
3. Decrease in thoracic vertebral bone attenuation with calcium-based phosphate binders in hemodialysis. Raggi P; James G; Burke SK; Bommer J; Chasan-Taber S; Holzer H; Braun J; Chertow GM J Bone Miner Res; 2005 May; 20(5):764-72. PubMed ID: 15824849 [TBL] [Abstract][Full Text] [Related]
4. Bone aluminum content in predialysis chronic renal failure and its relation with secondary hyperparathyroidism and 1,25(OH)2D3 treatment. Coen G; Mazzaferro S; Costantini S; Ballanti P; Carrieri MP; Giordano R; Smacchi A; Sardella D; Bonucci E; Taggi F Miner Electrolyte Metab; 1989; 15(5):295-302. PubMed ID: 2811788 [TBL] [Abstract][Full Text] [Related]
5. [The relationship between bone mineral density and secondary hyperparathyroidism bone disease]. Ning JP; Sun M; Toru I; Etsuo Y Hunan Yi Ke Da Xue Xue Bao; 2000 Feb; 25(1):77-9. PubMed ID: 12212259 [TBL] [Abstract][Full Text] [Related]
6. Changes of bone markers during long-term intravenous calcitriol therapy in maintenance dialysis patients. Lee SH; Huang TS; Hsieh SJ Miner Electrolyte Metab; 1996; 22(4):219-23. PubMed ID: 8807625 [TBL] [Abstract][Full Text] [Related]
7. Effect of parathyroidectomy on bone mineral density in hemodialysis patients with secondary hyperparathyroidism: possible usefulness of preoperative determination of parathyroid hormone level for prediction of bone regain. Yano S; Sugimoto T; Tsukamoto T; Yamaguchi T; Hattori T; Sekita KI; Kaji H; Hattori S; Kobayashi A; Chihara K Horm Metab Res; 2003 Apr; 35(4):259-64. PubMed ID: 12778370 [TBL] [Abstract][Full Text] [Related]
8. [Research on the treatment of secondary hyperparathyroidism as a complication of chronic renal failure]. Sugimura T Nihon Jinzo Gakkai Shi; 1991 Nov; 33(11):1119-34. PubMed ID: 1808363 [TBL] [Abstract][Full Text] [Related]
9. Increased bone turnover in late postmenopausal women is a major determinant of osteoporosis. Garnero P; Sornay-Rendu E; Chapuy MC; Delmas PD J Bone Miner Res; 1996 Mar; 11(3):337-49. PubMed ID: 8852944 [TBL] [Abstract][Full Text] [Related]
10. Effects of 22-oxacalcitriol and calcitriol on PTH secretion and bone mineral metabolism in a crossover trial in hemodialysis patients with secondary hyperparathyroidism. Ogata H; Koiwa F; Shishido K; Takahashi K; Ito H; Kinugasa E; Taguchi S Ther Apher Dial; 2007 Jun; 11(3):202-9. PubMed ID: 17498002 [TBL] [Abstract][Full Text] [Related]
11. [Osteocalcin in chronic hemodialysis patients as an additional parameter in the diagnosis of advanced secondary hyperparathyroidism]. Motz W Acta Med Austriaca; 1989; 16(1):8-12. PubMed ID: 2785325 [TBL] [Abstract][Full Text] [Related]
12. Chronic kidney disease/bone and mineral metabolism: the imperfect storm. Williams ME Semin Nephrol; 2009 Mar; 29(2):97-104. PubMed ID: 19371800 [TBL] [Abstract][Full Text] [Related]
13. [Relationship between weight, body composition and bone mass in peritoneal dialysis]. Negri AL; Barone R; Bogado CE; Zanchetta JR Nefrologia; 2005; 25(3):269-74. PubMed ID: 16053008 [TBL] [Abstract][Full Text] [Related]
14. [Investigation of the bone mineral density in hemodialysis patients for different terms]. Tao L; Xu H; Sun M; Ikeda T Hunan Yi Ke Da Xue Xue Bao; 1999; 24(2):177-8. PubMed ID: 11938784 [TBL] [Abstract][Full Text] [Related]
15. Effects of chronic liver disease on bone mineral density and bone metabolism markers in postmenopausal women. Uretmen S; Gol M; Cimrin D; Irmak E Eur J Obstet Gynecol Reprod Biol; 2005 Nov; 123(1):67-71. PubMed ID: 16051419 [TBL] [Abstract][Full Text] [Related]
16. Long-term effects of intravenous 1 alpha (OH)D3 combined with CaCO3 and low-calcium dialysis on secondary hyperparathyroidism and biochemical bone markers in patients on chronic hemodialysis. Brandi L; Daugaard H; Nielsen PK; Jensen LT; Egsmose C; Olgaard K Nephron; 1996; 74(1):89-103. PubMed ID: 8883025 [TBL] [Abstract][Full Text] [Related]
17. Efficacy of whole PTH assay and 1-84/non-(1-84) PTH ratio in patients on hemodialysis or undergoing parathyroidectomy. Kato Y; Yamaguchi S; Yachiku S; Fujisawa M; Kawakami N Hinyokika Kiyo; 2004 Nov; 50(11):755-62. PubMed ID: 15628534 [TBL] [Abstract][Full Text] [Related]
18. Secondary hyperparathyroidism due to hypovitaminosis D affects bone mineral density response to alendronate in elderly women with osteoporosis: a randomized controlled trial. Barone A; Giusti A; Pioli G; Girasole G; Razzano M; Pizzonia M; Palummeri E; Bianchi G J Am Geriatr Soc; 2007 May; 55(5):752-7. PubMed ID: 17493196 [TBL] [Abstract][Full Text] [Related]
19. [Clinical evaluation of osteocalcin in chronic hemodialysis patients]. Nishio S; Hayashi S; Yoshihara H; Kobayagawa H Hinyokika Kiyo; 1989 Nov; 35(11):1839-45. PubMed ID: 2618881 [TBL] [Abstract][Full Text] [Related]
20. Mineral metabolism, mortality, and morbidity in maintenance hemodialysis. Block GA; Klassen PS; Lazarus JM; Ofsthun N; Lowrie EG; Chertow GM J Am Soc Nephrol; 2004 Aug; 15(8):2208-18. PubMed ID: 15284307 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]